Multiple Sclerosis: Competitive Landscape to 2026

2018-07-13
Multiple Sclerosis: Competitive Landscape to 2026 Summary Multiple Sclerosis (MS) is primarily considered an inflammatory demyelinating disorder of the CNS due to a dysfunctional immune system, leading to neurological disability1. The etiology...

Gene Therapy in CVMD

2018-06-30
Gene Therapy in CVMD Summary Gene therapies have been a point of discussion during the last several years as a potential curative option for a variety of disease indications. While mainly still in preclinical stages, gene therapy aims to treat...

Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018

2018-05-18
Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2018” provides an...

Panic Disorders Global Clinical Trials Review, H1, 2018

2018-04-30
Panic Disorders Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Panic Disorders Global Clinical Trials Review, H1, 2018” provides an overview of Panic Disorders clinical trials scenario....

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area

2018-02-28
The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area Summary GlobalData’s “The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area”, provides an insight-rich overview of the key events and trends...

United Kingdom Tissue Engineered – Skin Substitute Procedures Outlook to 2024

2017-11-01
United Kingdom Tissue Engineered – Skin Substitute Procedures Outlook to 2024 Summary GlobalData’s new report, United Kingdom Tissue Engineered – Skin Substitute Procedures Outlook to 2024, provides key procedures data on the...

Mexico Tissue Engineered – Skin Substitute Procedures Outlook to 2024

2017-11-01
Mexico Tissue Engineered – Skin Substitute Procedures Outlook to 2024 Summary GlobalData’s new report, Mexico Tissue Engineered – Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Mexico Tissue...

France Tissue Engineered – Skin Substitute Procedures Outlook to 2024

2017-11-01
France Tissue Engineered – Skin Substitute Procedures Outlook to 2024 Summary GlobalData’s new report, France Tissue Engineered – Skin Substitute Procedures Outlook to 2024, provides key procedures data on the France Tissue...

Brazil Tissue Engineered – Skin Substitute Procedures Outlook to 2024

2017-11-01
Brazil Tissue Engineered – Skin Substitute Procedures Outlook to 2024 Summary GlobalData’s new report, Brazil Tissue Engineered – Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Brazil Tissue...

Germany Tissue Engineered – Skin Substitute Procedures Outlook to 2024

2017-11-01
Germany Tissue Engineered – Skin Substitute Procedures Outlook to 2024 Summary GlobalData’s new report, Germany Tissue Engineered – Skin Substitute Procedures Outlook to 2024, provides key procedures data on the Germany Tissue...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy